glp-1 news updates november 2025 Novo cuts GLP-1 prices 70%, but semaglutide revenue could grow in 2026 GLP-1 Trends – Understanding GLP-1s and their dynamic

Weight may increase slightly, partly from water retention as GLP-1 mediated effects on fluid balance normalize

[10] [11] Whilst these medications have proven benefits for glycaemic control and weight loss, their effects on gastrointestinal function mean they can influence digestive symptoms, which is particularly relevant for individuals with pre-existing bowel conditions such as IBS

When looked at closely, the muscles of those on GLP-1s appear to be healthier with less fat infiltration and better, stronger fibers, says cardiologist Ian Neeland at Case Western Reserve University

Liraglutide 3 mg/day resulted in a median weight loss of 9.7%, whereas WR was 1.8% in the placebo group at the end of 56 weeks [48]

Liquid calories